SCHEMBL6992081

SCHEMBL6992081

COc1ccccc1N1CCN(CCn2cnc3sc4c(c3c2=O)CCN(C(C)=O)C4)CC1

nearest known ligand 0.81

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 18/20 0.81
ADRA1D P25100 18/20 0.81
HTR1B P28222 18/20 0.81
ADRA1A P35348 18/20 0.81
ADRA1B P35368 18/20 0.81
P2RX3 P56373 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7718466 0.95 HTR1A (0.72) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL6993146 0.94 HTR1A (0.73) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL7675059 0.94 HTR1A (0.75) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL6994129 0.92 HTR1A (0.77) HTR1AADRA1DHTR1BADRA1AADRA1B
Hydrochloric Acid SCHEMBL7715124 0.91 HTR1A (0.76) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL6997238 0.89 HTR1A (1.00) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL6995317 0.88 HTR1A (0.84) HTR1AADRA1DHTR1BADRA1AADRA1B
Hydrochloric Acid SCHEMBL7722147 0.87 HTR1A (0.83) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL7000114 0.87 HTR1A (0.61) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL7673544 0.87 HTR1A (0.72) HTR1AADRA1DHTR1BADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0927184-B1 3-SUBSTITUTED PYRIDO 4',3':4,5]THIENO 2,3-D]PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE ABBOTT GMBH & CO KG (DE) 2003-10-22 EP disclosed
US-6387912-B1 STROKE THERAPY BASF AKTIENGESELLSCHAFT (DE) 2002-05-14 US disclosed
US-6222034-B1 AS SEROTININ RECEPTOR ANTAGONISTS; FOR THERAPY OF DEPRESSION, CENTRAL NERVOUS SYSTEM DISORDERS BASF AKTIENGESELLSCHAFT (DE) 2001-04-24 US disclosed